LPL Financial’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-10,412
| Closed | -$39.8K | – | 5251 |
|
2024
Q3 | $39.8K | Hold |
10,412
| – | – | ﹤0.01% | 4917 |
|
2024
Q2 | $30.5K | Sell |
10,412
-118,053
| -92% | -$346K | ﹤0.01% | 4799 |
|
2024
Q1 | $509K | Sell |
128,465
-3,062
| -2% | -$12.1K | ﹤0.01% | 3714 |
|
2023
Q4 | $654K | Sell |
131,527
-103,250
| -44% | -$513K | ﹤0.01% | 3398 |
|
2023
Q3 | $1.19M | Sell |
234,777
-70,685
| -23% | -$357K | ﹤0.01% | 2737 |
|
2023
Q2 | $1.54M | Sell |
305,462
-22,785
| -7% | -$115K | ﹤0.01% | 2470 |
|
2023
Q1 | $2.02M | Sell |
328,247
-50,213
| -13% | -$309K | ﹤0.01% | 2128 |
|
2022
Q4 | $5M | Sell |
378,460
-114,771
| -23% | -$1.51M | ﹤0.01% | 1451 |
|
2022
Q3 | $1.47M | Buy |
493,231
+298,731
| +154% | +$887K | ﹤0.01% | 2220 |
|
2022
Q2 | $710K | Buy |
+194,500
| New | +$710K | ﹤0.01% | 2868 |
|
2021
Q4 | – | Sell |
-45,436
| Closed | -$677K | – | 4404 |
|
2021
Q3 | $677K | Sell |
45,436
-5,614
| -11% | -$83.6K | ﹤0.01% | 2927 |
|
2021
Q2 | $641K | Buy |
+51,050
| New | +$641K | ﹤0.01% | 2933 |
|
2017
Q1 | – | Sell |
-634
| Closed | -$162K | – | 2773 |
|
2016
Q4 | $162K | Buy |
+634
| New | +$162K | ﹤0.01% | 2526 |
|